CMTM6 and gastric cancer: Interestingly, it was shown that co-expression of CMTM6 and CMTM4 on gastric cancer mesenchymal cells and epithelial cells predicts a poor prognosis and affects the effect of PD-1/PD-L1 immunotherapy (Wang et al., 2021).